Neodynamics
0,776 SEK −12,81%HC Andersen Capital on aikaisemmin saanut maksun yhtiöltä Neodynamics DigitalIR/Corporate Visibility -sopimuksesta. Tämä tarkoittaa, että sivulta voi löytyä maksettua materiaalia, jota ei ole päivitetty. Katso vastuuvapauslauseke.
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Viimeisimmät analyysit
Analyst
![Claus Thestrup Claus Thestrup](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://content.inderes.se/assets/637ef734-dcbf-426c-bf91-0ac4a79aa71e.png)
Viimeisimmät videot
Pörssikalenteri
Suurimmat omistajatLähde: Millistream Market Data AB
Omistaja | Osuus | Ääniä |
---|---|---|
Salénterprise AB | 39,9 % | 39,9 % |
Gryningskust Holding AB | 32,8 % | 32,8 % |
Inderes Premium
Tämä sisältö on vain Inderes Premium -käyttäjille.
NeoDynamics terminates the agreement with liquidity provider
NeoDynamics' stock is delisted from Nasdaq First North
Liity Inderesin yhteisöön
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.
FREE-tili
PREMIUM-tili
NeoDynamics applies for delisting
Bulletin from the annual general meeting in NeoDynamics AB (publ)
Update on NeoDynamics’ financial situation
NOTICE OF ANNUAL GENERAL MEETING IN NEODYNAMICS AB (PUBL)
NeoDynamics intends to apply for delisting
NeoDynamics Interim Report Jan-March 2024
NeoDynamics publishes Annual Report 2023
Update on NeoDynamics’ management team
Salénterprise increases its shareholding in NeoDynamics.
NeoDynamics announces the final outcome regarding the exercise warrants of series TO3
Update on NeoDynamics’ Management Team
NeoDynamics announces outcome of RIghts issue of shares
![HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/06aef4ac-f94b-407d-ac4d-dffe67b0f7a5.png)